KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,218,000 | -15.1% | 146,791 | -35.8% | 0.35% | -19.3% |
| Q1 2017 | $17,935,000 | +99.9% | 228,500 | +14.2% | 0.43% | +88.2% |
| Q4 2016 | $8,973,000 | -19.7% | 200,111 | +0.1% | 0.23% | -28.8% |
| Q3 2016 | $11,172,000 | +11.7% | 200,000 | 0.0% | 0.32% | +15.9% |
| Q2 2016 | $10,000,000 | +8.9% | 200,000 | 0.0% | 0.28% | -1.8% |
| Q1 2016 | $9,182,000 | +49.0% | 200,000 | +100.0% | 0.28% | +59.7% |
| Q4 2015 | $6,162,000 | – | 100,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|